Europska Unija - malteški - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cobicistat, atazanavir - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 u 5.

Europska Unija - malteški - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ritonavir - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - ritonavir huwa indikat flimkien ma 'aġenti antiretrovirali oħra għall-kura ta' pazjenti infettati bl-hiv-1 (adulti u tfal ta 'sentejn u akbar).

Europska Unija - malteški - EMA (European Medicines Agency)

cycle pharmaceuticals (europe) ltd - nitisinone - tyrosinemias - oħra tal-passaġġ alimentari u tal-metaboliżmu-prodotti, - it-trattament tal-pazjenti adulti u pedjatriċi b'dijanjosi kkonfermata ta 'tirosinemia ereditarja ta' tip 1 (ht-1) flimkien ma 'restrizzjoni tad-dieta ta' tyrosine u phenylalanine.

Europska Unija - malteški - EMA (European Medicines Agency)

guidehouse germany gmbh - sotagliflozin - id-dijabete mellitus, it-tip 1 - drogi użati fid-dijabete - zynquista huwa indikat bħala żieda mad-terapija ta'l-insulina biex itejbu l-kontroll gliċemiku f'adulti b'dijabete mellitus tip 1 bil-massa tal-Ġisem (bmi) ≥ 27 kg/m2, li ma rnexxilhomx jiksbu kontroll gliċemiku adegwat minkejja l-aħjar terapija ta'l-insulina.

Europska Unija - malteški - EMA (European Medicines Agency)

mylan pharmaceuticals limited - lopinavir, ritonavir - infezzjonijiet ta 'hiv - antivirali għal użu sistemiku - lopinavir / ritonavir huwa indikat flimkien ma 'prodotti mediċinali antiretrovirali oħra għat-trattament ta' adulti infettati bil-virus tal-immunodefiċjenza umana (hiv-1), adolexxenti u tfal 'il fuq minn sentejn. l-għażla ta 'lopinavir/ritonavir għall-kura ta' impedituri protease tal-hiv-1 f'pazjenti infettati għandha tkun ibbażata fuq testijiet tar-reżistenza virali u l-istorja tat-trattament tal-pazjenti.

Europska Unija - malteški - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - l-isklerożi multipla, sklerożi multipla li tirkadi u tbatti - immunosoppressanti - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Europska Unija - malteški - EMA (European Medicines Agency)

takeda pharma a/s - ixazomib citrate - majloma multipla - aġenti antineoplastiċi - ninlaro flimkien ma ' lenalidomide u dexamethasone huwa indikat għall-kura tal-pazjenti adulti bil-myeloma multipla li rċevew terapija għall-inqas wieħed minn qabel.

Europska Unija - malteški - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosoppressanti - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Europska Unija - malteški - EMA (European Medicines Agency)

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - oħra tal-passaġġ alimentari u tal-metaboliżmu-prodotti, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.

Europska Unija - malteški - EMA (European Medicines Agency)

teva pharma b.v. - capecitabine - colonic neoplasms; breast neoplasms; colorectal neoplasms; stomach neoplasms - aġenti antineoplastiċi - capecitabine teva huwa indikat għat-trattament awżiljarju ta 'pazjenti wara l-operazzjoni tal-istadju iii (dukes' stage c) kanċer tal-kolon. capecitabine teva huwa indikat għall-kura ta ' kanċer metastatiku tal-kolorektum. capecitabine teva huwa indikat għall‑kura preferita tal-kanċer gastriku avvanzat flimkien ma ' reġim ibbażat fuq il -. capecitabine teva flimkien ma 'docetaxel huwa indikat għall-kura ta' pazjenti b'lokalment avvanzat jew tal-kanċer tas-sider metastatiku wara l-falliment tal-kimoterapija ċitotossika. it-terapija ta 'qabel kellha tinkludi anthracycline. capecitabine teva huwa wkoll indikat bħala monoterapija għall-kura ta 'pazjenti b'lokalment avvanzat jew tal-kanċer tas-sider metastatiku wara l-falliment ta' taxanes u ta 'kors ta' kimoterapija li fihom jew li għalihom l-aktar anthracycline ma tkunx indikata t-terapija.